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Abstract
Microglia are the resident macrophages in the central nervous system. In the spinal cord dorsal horn, microglia stay
in resting condition during physiological sensory processing, and are activated under pathological conditions such
as peripheral nerve injury. In cases such as this, the nearby resting microglia increase their motility and accumulate
at the site of injury. However, direct evidence to support that nerve activity can enhance the motility of microglia
has not yet to be reported. In this study we investigated whether the activation of spinal microglia under in vivo
nerve injury may be mimicked by neuronal activity in the spinal cord slice preparation. We found that local appli-
cation of spinal excitatory neurotransmitters, such as glutamate and substance P did not cause any change in the
motility of microglial cells in the spinal cord dorsal horn. The motility of microglial cells is unlikely modulated by
other transmitters, neuromodulators and chemokines, because similar applications such as GABA, serotonin, nora-
drenaline, carbachol, fractalkine or interleukin did not produce any obvious effect. Furthermore, low or high fre-
quency stimulation of spinal dorsal root fibers at noxious intensities failed to cause any enhanced extension or
retraction of the microglia processes. By contrast, focal application of ATP triggered rapid and robust activation of
microglial cells in the spinal dorsal horn. Our results provide the first evidence that the activation of microglia in
the spinal cord after nerve injury is unlikely due solely to neuronal activity, non-neuronal factors are likely responsi-
ble for the activation of nerve injury-related microglial cells in the spinal dorsal horn.
Background
Microglial cells are the principal immune-response cells
in the central nervous system (CNS) [1,2]. In physiologi-
cal conditions, they are found in a “resting” state - typi-
cally exhibiting ramified processes with high motility [3].
Under pathological conditions, these cells are trans-
formed from the resting condition to an activated condi-
tion, exhibiting phagocytoxic, chemotaxis and secretory
reactions [4-6]. A growing body of literature indicates
that spinal microglia can be activated after nerve injury
[4,5], suggesting the possibility that neuronal activity
may contribute to microglia activation. This possibility
is further supported by studies showing that several
neurotransmitter receptors can be expressed on cultured
microglia cells, including NMDA, GABA, opioid and
adrenergic receptors [7-11]. However, in a recent study
using the brain slice preparation for adult mice, we
f o u n dt h a tm i c r o g l i ad i dn o tr e s p o n dt oe i t h e ra
glutamate or GABA application, or activity-dependent
long-term potentiation (LTP) [12]. In addition to these
findings, we found that nerve injury did not cause any
activation of microglial cells in supraspinal central
nuclei such as the anterior cingulate cortex (ACC)
where excitatory synaptic transmission was significantly
enhanced after nerve injury [13]. In support of previous
reports in the spinal cord, we also found that microglial
cells were activated in spinal cord dorsal horn after the
nerve injury [13]. One possible explanation is that spinal
microglia may be more sensitive to abnormal neuronal
activity than those in higher brain regions.
The spinal cord dorsal horn is a key area for nocicep-
tive transmission and modulation [14]. In the spinal
cord, LTP is proposed to be the key cellular mechanism
for pathological pain [14,15]. Noxious stimuli of sciatic
nerve or hindpaw can induce LTP in spinal dorsal horn
neurons [15,16]. Although microglia in the spinal cord
is believed to play an important role in neuropathic pain
[4,13,17], it is still unclear if LTP inducing protocols
activates spinal microglia. To test this possibility, we
investigated the motility of microglia in the dorsal horn
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any medium, provided the original work is properly cited.of spinal cord slices of transgenic mice with green fluor-
escent protein (GFP) exclusively expressed in microglia
[12,18]. Chemicals known to mimic or enhance neuro-
nal activity were applied locally. Electrical stimulation of
the dorsal root fibers that has been known to induce
spinal LTP was also tested. We found that the activation
of the spinal microglia is independent of synaptic or
neuronal activity, and the activation after nerve injury is
unlikely driven by nerve activity in an activity-dependent
manner.
Results
To investigate the microglial cells in spinal cord dorsal
horn, we used transgenic mice with GFP-labeled micro-
glia cells as previously reported [12,18-20]. Similar to
microglial cells in supraspinal structures in vivo and in
vitro [12,13,20], most of the microglia cells in the spinal
cord slices showed ramified with active moving pro-
cesses, while hypertrophied, monopolarized, bipolarized
and amoeboid cells were also observed. These results
suggest that the status of microglia in in vitro spinal
cord slices is similar to those in spinal dorsal horn in
vivo. Under the confocal microscope, the processes of
ramified microglia in brain slices were very dynamic,
showing rapid extensions and retractions with a speed
of 1 μm/min.
Effect of excitatory neurotransmitters on the motility of
microglia in spinal dorsal horn
Glutamate is the major excitatory neurotransmitter in
the spinal cord dorsal horn [21]. To test if glutamate
may activate spinal microglial cells, we locally applied
(1 or 10 mM) glutamate to spinal microglial cells using
a picopump application system [12]. We found that glu-
tamate application did not cause any effect on the moti-
lity of microglia. No change in the motility of processes,
either extension or retraction, was detected (Fig. 1, Fig.
2A). The processes of microglia showed a withdrawal
tendency over the time. This is called “rundown” effect
in microglial motilities, identified with gradually
declined extension and retraction [12]. The ratio of
extended/retracted processes or distances of microglia at
time 30 min to 0 min after application of glutamate (1
mM, n = 6 slices/5 mice) was shown in Fig. 1. The ratio
Figure 1 Summarized effect of different kinds of neurotransmitters, neuromodulators and chemokines on the extension and
retraction percentage of microglia in spinal dorsal horn. The ratio of extended or retracted processes and distances of microglia at time 30
min to 0 min after drug application are shown. ATP are applied at 1 or 10 mM; Glu, AMPA, NMDA, DHK, SP, GABA, Glycine, 5-HT, NA, Carbachol
and Morphine are applied at 1 mM; MCP-1, FKN, NGF, BDNF, IL-1b, IL-6 and TNF-a are applied at 10 ng/ml. The results of application of 10 mM
Glu, AMPA, NMDA, DHK, SP, GABA, Glycine, 5-HT, NA, Carbachol and Morphine and 100 ng/ml MCP-1, FKN, NGF, BDNF, IL-1b, IL-6 and TNF-a are
similar. ATP 1, ATP 1 mM; ATP 10, ATP 10 mM; Glu, Glutamate; DHK, dihydrokainate; NA, noradrenalin; SP, Substance P; MCP-1, monocyte
chemoattractant protein-1; FKN, fractalkine; NGF, nerve growth factor; BDNF, brain-derived neurotrophic factor; IL-1b, interleukin-1b; IL-6,
interleukin-6; TNF-a, tumor necrosis factor-a.
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Page 2 of 13of extended/retracted process and distances of microglia
after 10 mM glutamate application (n = 5 slices/5 mice)
is no statistical difference from those in group with
1 mM glutamate application (p > 0.05).
We also applied AMPA and NMDA at different doses
(1 or 10 mM) to examine if microglial cells may be acti-
vated. Similar to the results of glutamate, neither AMPA
nor NMDA application affect the status of microglial
cells in the spinal cord dorsal horn (n = 4 slices/4 mice
in each group; Fig. 1, Fig 2B-C). To examine if the
enhancement of local glutamate by inhibiting glutamate
uptake may affect microglia, we also applied the selec-
tive glutamate uptake inhibitor dihydrokainate (DHK) at
1 or 10 mM. We found that DHK did not cause any
obvious effect (n = 4 slices/3 mice; Fig 1, Fig 2D). In
addition to glutamate, Substance P (SP) is a neuropep-
tide that contributes to nociceptive sensory transmission
i nt h es p i n a lc o r d[ 2 2 ] .T ot e s ti fS Pm a yt r i g g e ra n y
activation of microglia, we performed local application
of SP at two different doses (1 or 10 mM). Similarly, SP
did not induce any obvious enhancement in the motility
of microglia (n = 5 slices/5 mice in each group; Fig. 1,
Fig 2E).
Effect of inhibitory neurotransmitters on the motility of
microglia in spinal dorsal horn
GABA and glycine are two major inhibitory transmitters
in the spinal cord dorsal horn. If microglia can be regu-
lated by synaptic activity, we expect that application of
GABA or glycine may reduce the motility of microglia.
After local application of all of these drugs (1 or
10 mM), no significant change in motility was observed
(Figs. 3A-B). The ratio of extended/retracted processes
and distances of microglia at time 30 min to 0 min after
application of 1 mM GABA (n = 6 slices/6 mice) or gly-
cine (n = 5 slices/4 mice) were summarized in Fig. 1.
The ratio of extended/retracted process or distances of
microglia after 10 mM GABA (n = 5 slices/5 mice) or
glycine (n = 5 slices/4 mice) application is not statisti-
cally different from those with 1 mM GABA or glycine
application (p > 0.05). These results suggest that enhan-
cing spinal inhibitory transmission did not affect the
motility of microglia.
Effects of neuromodulators on the motility of microglia in
spinal dorsal horn
Spinal nociceptive transmission is regulated by multiple
neurotransmitters released locally or from descending
projection fibers, including serotonin (5-HT), noradrena-
lin (NA), acetylcholine and opioid peptide [23-27].
Because neither excitatory transmitter glutamate nor
inhibitory neurotransmitter GABA/glycine enhance the
motility of microglia, we decided to examine whether
neuromodulators have affect on the motility of
microglia. Agonists that activate the neuromodulators’
receptors, including 5-HT, NA, carbachol and morphine,
were applied at two different doses (1 or 10 mM). After
application of 1 mM 5-HT (n = 4 slices/4 mice), NA
(n = 5 slices/4 mice), carbachol (n = 5 slices/4 mice) or
morphine (n = 6 slices/5 mice), however, no significant
enhancement of the motility of microglia was observed
(Figs. 3C-F). The ratios of extended/retracted processes
or distances of microglia were summarized in Fig. 1.
The ratios of extended/retracted processes or distances
after 10 mM drug application were similar to those after
drug application (p > 0.05).
The effect of the stimulation of dorsal root on the
motility of microglia
Activity-dependent synaptic plasticity is thought to be
important for the formation of hyperalgesia, in which
microglia is believed to be activated and play important
roles [4,28-30]. In the spinal cord dorsal horn, it’s
reported that two kinds of stimulation patterns (low fre-
quency stimulation (LFS) and high frequency stimuli
(HFS)) can induce LTP effect in different portion of
neurons [15,28,29]. Thus, we decided to test the effects
of LFS and HFS on the motility of spinal microglia. LFS
or HFS was delivered by a suction electrode at an inten-
sity sufficient to activate Aδ and C fibers (Fig. 4). To
study the extension and retraction of microglia pro-
cesses, the number and distance of extending and
retracting microglial processes was calculated. Further-
more, the percentage of the extension or retraction
volume 10 min before and 30 min after the LFS and
HFS induction were calculated. Fig. 5A shows one sam-
ple from control, LFS and HFS group respectively at
time 10 min and 30 min. Data is summarized in Fig. 5B.
Six microglia from six separate slices were counted in
each group, and a similar rundown of microglial motili-
ties were found during and after stimuli were applied.
No significant difference in microglial motilities, such as
the number (9.0 ± 1.6, 7.8 ± 2.0 or 8.4 ± 2.0 in control,
LFS or HFS group, P >0.05), distance (μm) (12.1 ± 1.6,
11.8 ± 0.9 or 11.1 ± 2.2 in control, LFS or HFS group,
P > 0.05), or volume (%) (66.0 ± 6.7, 59.4 ± 2.3 or 60.5
± 4.2 in control, LFS or HFS group, P > 0.05) of exten-
sion were observed. Similarly, there was no significant
difference in all of these parameters of retraction before
and after LFS or HFS (P > 0.05) (Fig. 5B).
Peripheral nerve injury can also increase the number
of microglia in spinal dorsal horn [5,13,17]. If short time
stimulation (like LTP induction) on the dorsal root can
activate microglia, it may also cause the similar results
on spinal cord slices. The more likely effect should be
microglia cells redistributed, in which microglia in the
middle part of the spinal cord may be attracted by, and
approach close to, the dorsal root. To test this proposal,
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Page 3 of 13Figure 2 Effect of excitatory neurotransmitters on the motility of microglia in spinal dorsal horn.( A-E). Local application of 1 mM
glutamate (Glu), AMPA, NMDA, glutamate uptake inhibitor dihydrokainate (DHK) or substance P (SP) cannot increase the motility of microglia.
Dotted circle indicates the center of the drug application area. Microglial motility was imaged every 2 min for 30 min. The first image (0 min,
left) and last image (30 min, middle) were shown here. To observe clearer motility, the 2 images were merged (right) and set as green and red
for 0 and 30 min, respectively. Therefore the green reflects retracted portions, and the red reflects extended portions, whereas the yellow reflects
unaltered portions. Bars equal to 20 μm.
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Page 4 of 13Figure 3 Effect of inhibitory neurotransmitters and neuromodulators on the motility of microglia in spinal dorsal horn.( A-F). Local
application of 1 mM GABA, Glycine, 5-HT, noradrenalin (NA), acetylcholine agonist carbachol and morphine had no effect on microglia motility.
The merged picture is the overlay of imaging at 0 min (green) and 30 min (red) after drug local application. Note that (F) showed the result
recorded on typical amoeboid cells. Bars equal to 20 μm.
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Page 5 of 13Figure 4 Histological results of dorsal root stimuli on the motility of microglia in spinal dorsal horn.( A). Schematic representation of the
confocal imaging and field potential recording accompany with dorsal root stimuli; (B). Digitized photomicrographs of the dorsal root stimuli
model in a transverse spinal cord section. (C). Observation of microglia in one fixed section of spinal cord after low frequency dorsal root stimuli.
Rectangled areas in (C) were magnified in (D) and (E) respectively. Ipsi., ipsilateral part of dorsal root; Contro., controlateral part of dorsal root.
Bars equal to 100 μmi n( C) and 50 μmi n( D) and (E).
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Page 6 of 13Figure 5 Effect of low or high frequency stimuli to the dorsal root on the motility of microglia in spinal dorsal horn.( A). Sample
images showing the extension and retraction of microglia in control (top), low frequency stimulation (LFS) (middle) and high frequency
stimulation (HFS) induction groups (bottom). Right image is showing the microglia at 10 min and 30 min after imaging. LTP induction was
delivered at time 10 min. (B). Extension (top) and retraction (bottom) of microglia in LTP induction groups is similar to that in control group. The
number, distance, and percentage of volume of extension or retraction processes were measured. Note that the “rundown” of microglial
extension was found in the three groups.
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Page 7 of 13we fixed the spinal cord slices after LFS or HFS, then
checked the number and distribution pattern of micro-
glia in spinal cord slices. The number of the microglia
bodies in 30 μm sections in layers I-V ipsilateral or con-
tralateral to the dorsal root stimulation site was calcu-
lated and compared. After LFS or HFS, we found that
the number of microglia in different layers, as well as
the morphology of microglia were not significantly
affected (P > 0.05, n = 6 mice in each group) (Table 1
and Table 2).
Effect of chemokines on the motility of microglia in
spinal dorsal horn
Chemokines, especially MCP-1 and FNK, have been sug-
gested to contribute to microglia activation [4,31,32].
However, in the present study, we found that applica-
tion of MCP-1 or FNK did not affect the motility of
microglia in the spinal cord slices (Figs. 6A-B). The
ratios of extended/retracted processes or distances of
microglia at time 30 min to 0 min after application of
10 ng/ml MCP-1 (n = 6 slices/5 mice) or FNK (n = 5
slices/5 mice) were summarized in Fig. 1. Similar results
were also found with 100 ng/ml MCP-1 or FNK.
In spinal cord dorsal horn, activated microglia can
r e l e a s es o m ec h e m o k i n e sl i k eN G F ,B D N F ,I L - 1 b,I L - 6
and TNF-a. These factors may spread and activate adja-
cent microglia and neurons [4,5,17,33]. To test the pos-
sible effects on spinal microglia, we applied them (10 or
100 ng/ml) to the microglia cells in spinal cord slice
preparation. Application of NGF (n = 4 slices/3 mice),
BDNF (n = 5 slices/4 mice), IL-1b (n = 6 slices/6 mice),
IL-6 (n = 5 slices/4 mice) or TNF-a (n = 6 slices/5
mice) did not enhance the motility of the microglia
(Figs. 6C-G). The ratios of extended/retracted processes
or distances of microglia after application of 10 ng/ml
NGF, BDNF, IL-1b, IL-6 or TNF-a were summarized in
Fig. 1.
Effect of ATP on the motility of microglia in spinal dorsal
horn
ATP is known to be a key regulator for microglia during
the injury. Microglia expresses both ionotropic (P2X)
and metabotropic (P2Y) ATP receptors. Under both in
vivo and in vitro brain slice conditions, it has been
reported that ATP induced an obvious enhancement of
the motility of microglia and caused a chemotaxis effect
[3,12,19,20]. In the present study, we wanted to examine
if similar results can be found in spinal cord slices.
Application of ATP at a low (1 mM) or a high (10 mM)
concentration induced obvious effects on the motility of
microglia. Microglia stretched out with terminals mov-
ing towards the site of the injection pipette. The micro-
glia terminals extended toward the tip of the pipette
with an average velocity of 0.8 ± 0.3 μm/min (1 mM,
n = 12) or 1.4 ± 0.2 (10 mM, n = 14). At 20-30 min
after the injection, the processes reached the site, form-
ing a spherical shield around it (Fig. 7). The ratio of
extended processes and distances at time 30 min to
0 min after application of 1 mM (n = 5 slices/4 mice) or
10 mM (n = 6 slices/4 mice) ATP were shown in Fig. 1.
Discussion
In this study, by combining a time lapse confocal ima-
ging and histological observation, we demonstrated that
motility of microglia in the spinal dorsal horn is not dri-
ven by neuronal activity directly. Stimulation of sensory
afferent fibers at noxious intensities did not cause any
activation of microglial cells. Furthermore, stimulation
protocols that are known to induce long-term plasticity
in spinal cord dorsal horn neurons failed to trigger any
alteration in microglia. These results are important as
they provide the first evidence that spinal microglia are
not likely regulated by sensory inputs under physiologi-
cal or pathological conditions. Although recent studies
confirmed the activation of spinal microglia by nerve
injury using the same transgenic mice [13], we suggest
that activation of microglia in animal models for neuro-
pathic pain is likely caused by non-neuronal factors
after nerve injury. However, we cannot rule out the pos-
sibility that the microchemical environment within
spinal microglial cells may change and release chemical,
diffusible molecules.
In physiological conditions, the majority of microglia
are found to be in a resting state. They have ramified
Table 1 Number of microglia cells in layer I-V of spinal
dorsal horn after low frequency dorsal root stimuli
(n = 6)
Lamina Ipsilateral (number/mm
2,
Mean ± SEM)
Contralateral (number/mm
2,
Mean ± SEM)
I 314.5 ± 19.4 301.5 ± 12.8
II 289.7 ± 15.3 273.1 ± 16.4
III 212.1 ± 22.3 226.2 ± 17.8
IV 180.5 ± 10.8 165.4 ± 17.2
V 182.3 ± 16.7 183.8 ± 14.3
Table 2 Number of microglia cells in layer I-V of spinal
dorsal horn after high frequency dorsal root stimuli
(n = 6)
Lamina Ipsilateral (number/mm
2,
Mean ± SEM)
Contralateral (number/mm
2,
Mean ± SEM)
I 331.5 ± 22.3 311.1 ± 16.7
II 290.7 ± 18.4 293.9 ± 17.7
III 224.3 ± 23.9 242.0 ± 18.8
IV 197.1 ± 18.2 177.0 ± 16.3
V 190.8 ± 14.5 182.7 ± 10.9
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Page 8 of 13Figure 6 Effect of chemokines on the motility of microglia in spinal dorsal horn.( A-G). Local application of 10 ng/ml monocyte
chemoattractant protein-1 (MCP-1), fractalkine (FKN), nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), interleukin 1b (IL-1b),
interleukin 6 (IL-6) or tumor necrosis factor a (TNF-a) had no effect on microglia motility. The merged picture is the overlay of imaging at 0 min
(green) and 30 min (red) after drug application. Figs. (E-G) showed the results recorded on amoeboid cells. Bars equal to 20 μm.
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Page 9 of 13processes with continuous extending and retracting
reaction for detecting changes [3,19]. Our previous work
of cortical and hippocampal slices confirm the existence
of similar resting microglial cells within the central ner-
vous system. In animal models of neuropathic pain in
rats and mice, activation of microglia were consistently
observed as discussed in our recent paper. One major
hypothesis is that the activation of microglia by nerve
injury is caused by abnormal sensory input activity.
However, in the present study, we found that microglial
cells were not activated by nerve activity or application
of different chemicals that mimic sensory transmission
and modulation. One possible explanation for this fail-
u r et oa c t i v a t ei st h eu s eo fi nv i t r os l i c ep r e p a r a t i o n .
Our recent studies however favor the use of brain/spinal
slice preparation for the investigation of microglia
[12,20,34]. In all slice preparations including the present
study, we found that the basal microglia are similar to
in vivo resting microglia in the same brain region, and
application of ATP but not Glu and GABA can enhance
the motility of microglia [12,20].
Despite the expression of AMPA, NMDA, GABA,
opioid and adrenergic receptors on cultured microglia
[7-11], the present study showed no effect of different
receptor agonists on the resting microglia in acute
spinal cord slices. We propose that microglia in CNS
may not be ‘simply’ activated by neuronal activity or
LTP/LTD like plasticity.
Chemokines are one kind of signal involved with
microglia activation. Among them, MCP-1 and FKN are
considered as neuronal-microglia signals. They are
reported to be expressed on DRG neurons and spinal
dorsal horn neurons after nerve injury [35-39]. MCP-1
and FKN can combine to their receptors [4,31,32]
expressed on microglia and induce their activation. Con-
sequently, activated microglia release chemokines like
BDNF, NGF, IL-1b, IL-6 and TNF-a, which act on resi-
dent microglia and neurons and result in continuous tis-
sue sensitization and exaggerated pain [6,40-42]. In this
study, we didn’t find any enhanced motility of microglia
after local application of MCP-1, FKN, BDNF, NGF, IL-
1b,I L - 6a n dT N F - a, indicating that a single chemokine
is not powerful enough to enhance the motility of
microglia in spinal cord slices.
In the present study, ATP application but not dorsal
root stimulation can cause increased motility of micro-
glia. This finding confirms that microglial cells in spinal
cord slice preparation are similar to those in vivo in
term of ATP sensitivity.C o n s i d e r i n gA T Pc a nb e
released from efferent terminals after dorsal root stimu-
lation [9], we think that removing the possible inhibitory
elements in the circumstance context in pathological
condition may be important for the activation of micro-
glia. In normal condition, dorsal root stimulation
induced synaptic release of ATP may be rapidly degra-
dation by ATP-hydrolyzing enzyme in situ and cannot
reach a high degree to increase the motility of microglia
[9].
Although no enhanced motility of microglia was
observed, it does not exclude the possibility that bio-
chemical changes may happen after drug application or
LTP induction within microglial cells. After peripheral
nerve injury, the first changes in spinal microglia are the
withdrawal processes and enlarged soma [5], which is
similar to the “rundown” phenomenon observed in our
study and reflects a gradual activation of microglia.
Since the increased number of microglia in spinal cord
only reach the peak 2-3 days after nerve injury, the neu-
ronal activity and LTP induction induced activation of
m i c r o g l i am a yb eas l o w l yp r o c e d u r e[ 5 , 1 3 ] .I nc u r r e n t
study, thirty minutes observation may be not long
enough for detecting possible chronic activation of
microglia, long-term observations under in vivo condi-
tions should be carried out in the future to study if
microglia in spinal cord can be activated after dorsal
root stimulation.
In summary, our work on the spinal cord dorsal horn
indicates that the motility of spinal microglia cannot be
Figure 7 Effect of ATP on the motility of microglia in spinal dorsal horn. Local application of ATP (1 mM) induced rapid movement of
microglial processes toward the tip of puff pipette in acute spinal cord slices. Three time points of 0 min, 10 and 30 min after ATP application
were shown here. Bar equals to 20 μm.
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Page 10 of 13enhanced by dorsal root stimuli or local application of
neurotransmitters, neuromodulators and chemokines,
which is consistent with our previous works on brain
slices. These results suggest that resting microglia in the
CNS may not be directly related to synaptic transmis-
sion and plasticity. Activation of microglia in a cultured
dish or in vivo m a yb ed u et ot h ec o m b i n e de f f e c t so f
the co-release of several signals and removal of inhibi-
tory factors.
Methods
Transgenic mice
Heterozygous Cx3cr1
GFP/+ mice were used for all the
experiments [18]. All mice were maintained on a 12-h
light/dark cycle with food and water provided ad libi-
tum. All protocols used were approved by The Animal
Care and Use Committee at the University of Toronto.
Acute spinal cord slice preparation
Adult male or female mice (6-10 wks old) were anesthe-
tized with 1-2% urethan, and body temperature was
kept in the range 35-37°C with an infrared lamp. A lum-
bosacral laminectomy was performed and a 1-2.0 cm
length of spinal cord with attached dorsal roots was
excised. The spinal cord was placed in cold (0-4°C) oxy-
genated (95% O2-5% CO2) artificial cerebrospinal fluid
(ACSF) solution containing (in mM) 124 NaCl, 25
NaHCO3, 2.5 KCl, 1 KH2PO4, 2 CaCl2,2M g S O 4,a n d
10 glucose. After removal of the dura mater, all ventral
and dorsal roots, with the exception of the L3 or L4
dorsal root on one side, were cut near the root entry
zone. The pia-arachnoid membrane was then removed,
sparing the area around the site of insertion of the pre-
served dorsal root. The spinal cord, together with the
attached dorsal root, was placed in a shallow groove
formed in an agar block. The spinal cord was immersed
in cold ACSF solution and a transverse slice (500-700
μm) with attached dorsal root was cut with a Vibratome
according to the protocols reported before [43,44]. The
slice was then completely submerged and superfused
continuously with ACSF solution equilibrated with 95%
O2,5 %C O 2 at room temperature for 1 hour and then
transferred to a recording chamber and perfused with
oxygenated ACSF solution at 3-4 ml/min at 34 ± 1°C.
The dorsal root of the spinal cord slice was then sucked
into a suction electrode for electronic stimuli.
Spinal cord slices without dorsal root were also pre-
pared for local drug microinjection. All the procedures
for making slices are the same to those mentioned
above except that all the dorsal roots and pia-arachnoid
were thoroughly removed from the surface of the spinal
cord and spinal cord slices without dorsal roots were
cut. Local drug application and LTP induction were car-
ried out in slices within 3 hrs after cutting operation for
observing the motility of ramified microglia and in slices
more than 3 hrs to observe the motility of ameboid
microglia cells.
Confocal imaging
GFP-labeled microglia in dorsal horn of the spinal cord
(layers I-V) were imaged by confocal microscope (Fluo-
view FV 1000, Olympus, Tokyo, Japan). The laser with a
wavelength of 488 nm was used for GFP excitation, and
633 nm was used for DIC images. The image of micro-
glia was collected for 8-10 consecutive focal steps of
2 μm once every 2 min using × 40, 0.8 numeric aperture
water-immersion objectives. XYZT image galleries were
collected, and Z projections were made for the
quantification.
Local Drug microinjection procedures
All drugs were obtained from Sigma (St. Louis, MO,
USA) except monocyte chemoattractant protein-1
(MCP-1), fractalkine (FKN), nerve growth factor (NGF),
brain-derived neurotrophic factor (BDNF), interleukin
(IL)-1b, IL-6 and tumor necrosis factor (TNF)-a (Pepro-
tech, Embrun, Canada). A picopump (pneumatic pico-
pump, WPI, Sarasota, FL) was used to apply
neurotransmitters, neuromodulators and cytokines to
induce microglial chemotaxis according to our previous
reports [12]. The diameter of the drug application pip-
ette tip was 3-4 μm. The pressure and duration of the
puff was 5 psi and 100 ms, respectively.
Recording and stimulation
To study the effect of electronic stimuli on microglial
motilities, the 40 volt, 0.5 ms low frequency (LFS, 2 Hz,
2-3 min) or high frequency (HFS, 100 Hz, given in 5
trains of 1 s duration at 10 s intervals) electronic sti-
muli, which were proved to induce LTP effect in differ-
ent groups of spinal dorsal horn neurons, were delivered
through the electrode [15,28,29]. To make sure that the
stimuli could be carried out properly, a field recording
electrode was used for field excitatory postsynaptic
potential (EPSP) recording. The recording electrode was
filled with ACSF and inserted into ipsilateral part of the
layer V-VI, 200-300 μm far away from the confocal ima-
ging area. The field EPSP data was amplified and filtered
by Axopatch 200B amplifier, digitalized by Digidata
1322A and analyzed by pClamp 8.0 software (Molecular
Devices, Union City, CA).
Histology
After the procedure for dorsal root stimuli and confocal
imaging, spinal cord slices with dorsal root would be
kept staying in ACSF for one hour and then removed to
fixation solution containing 4% paraformaldehyde in
0.01 M phosphate buffered saline (PBS, pH 7.4) for 24
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Page 11 of 13hrs. Subsequently, the spinal cords were placed into 30%
(w/v) sucrose in 0.01 M PBS overnight at 4-8°C. After
making a pinhole in the ventral part of the sample con-
tralateral to the dorsal root, the fixed spinal cord was
cut serially into 30 μm-thick frontal sections on a freez-
ing microtome (Kryostat 1720; Leitz, Mannheim, Ger-
many). Then the serial sections were mounted onto
glass slides, air dried, cover-slipped with a mixture of
50% (v/v) glycerin and 2.5% (w/v) triethylene diamine in
0.01 M PBS, and observed with the confocal microscope
(FV 1000; Olympus).
Data analysis
The microglial motilities were analyzed by using Image-
Pro Plus software (IPP 5.0., Media cybernetics, Silver
Spring, USA). The number, distance, and volume of
extending and retracting microglial processes were cal-
culated every 2 min. Microglia quantification was per-
formed on sections of 30 μm thickness. Only the cell
bodies were taken into account. Cell counting was per-
formed by using confocal microscope under 20× objec-
tive through IPP 5.0 software. Layers I-V in ipsilateral
and controlateral sites of dorsal root were examined for
each of the three randomly selected sections per mouse.
Data were expressed as mean ± SEM. Statistical com-
parisons were performed with the Student’s t-test. In all
cases, P < 0.05 was considered statistically significant.
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